4.8 Article

Engineered Nanostructured Facial Lipopeptide as Highly Efficient Molecular Transporter

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 7, Issue 33, Pages 18397-18405

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.5b04392

Keywords

peptides; molecular transporter; drug delivery; nanoparticle; biopharmaceuticals; lipopeptide

Funding

  1. DBT Ramalingaswami [BT/HRD/35/02/2006]
  2. DBT Nanobiotechnology [BT/PR6761/NNT/28/619/2012]
  3. USER Kolkata
  4. DBT for Ramalingaswami fellowship
  5. CSIR
  6. IISERK for Ph.D. fellowship

Ask authors/readers for more resources

Designing an effective peptide based molecular transporter for the intracellular delivery of hydrophilic therapeutic biomacromolecules remains a considerable challenge. Highly basic oligoarginine and lipidated arginine rich cell penetrating peptides have been reported in the literature as molecular transporters, which were extensively used for cellular internalization of significantly large biopharmaceuticals. However, oligoarginine based molecular transporters with L-arginine residues pose significant challenges due to proteolytic instability and limited stability of noncovalent peptide cargo nanocomplexes. Exploiting the rational peptide designing strategy, we have engineered protease-resistant facial lipopeptide based molecular transporter having arginine-sarcosine-arginine moiety to minimize adjacent arginine-arginine pair repulsion. N-Methylated amino acid sarcosine was incorporated as a spacer between two adjacent arginine residues, which provides proteolytic stability to the designed peptide and minimizes intermolecular aggregation of peptides. Two stearyl moieties were incorporated to facilitate cellular internalization. Interestingly, our designed lipopeptide exhibits significantly enhanced cellular internalization with only six L-arginine residues compared to stearylated oligo-nona-arginine. Additionally, enhanced proteolytic stability of such class of molecular transporter enables increased cargo internalization, and we anticipate that our engineered multifunctional, proteolytically stable, nanostructured facial lipopeptide based molecular transporter can have major impact in advancing drug delivery technologies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available